Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2010

May 17, 2010

30198_dirs_2010-05-17_658b4144-ecc7-48e2-b927-7faffdd5b8a4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2010-05-13

Reporting Person: MOY JEFFREY (V. P., Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-05-13 Common Stock M 3593 $7.63 Acquired 71244 Direct
2010-05-13 Common Stock M 3013 $6.33 Acquired 74257 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-05-13 Incentive Stock Option (right to buy) $6.33 M 3013 Disposed 2018-09-24 Common Stock (3013) Direct
2010-05-13 Incentive Stock Option (right to buy) $7.63 M 3593 Disposed 2018-05-19 Common Stock (3593) Direct

Footnotes

F1: The option vests and becomes exercisable with respect to 1/4th of the shares one year after the date of grant, and thereafter continues to vest and become exercisable as to 1/48th of the shares each month thereafter (with the shares fully vested on the 4th anniversary of the date of grant).